Hedge Fund - Driehaus Capital
Xenon Pharmaceuticals Inc. (XENE)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $153,822,019 | 1.48% | 4,584,859 | $37.97 |
| 2 | 2024 - Q4 (2024-12-31) | $177,207,324 | 1.46% | 4,520,595 | $41.35 |
| 3 | 2024 - Q3 (2024-09-30) | $180,933,536 | 1.55% | 4,595,721 | $40.32 |
| 4 | 2024 - Q2 (2024-06-30) | $172,315,213 | 1.66% | 4,419,472 | $39.97 |
| 5 | 2024 - Q1 (2024-03-31) | $186,050,907 | 1.85% | 4,321,740 | $46.00 |
| 6 | 2023 - Q4 (2023-12-31) | $200,138,991 | 2.41% | 4,345,180 | $35.33 |
| 7 | 2023 - Q3 (2023-09-30) | $154,164,251 | 2% | 4,513,005 | $37.40 |
| 8 | 2023 - Q2 (2023-06-30) | $183,292,841 | 2.31% | 4,760,853 | $39.75 |
| 9 | 2023 - Q1 (2023-03-31) | $166,599,766 | 2.33% | 4,654,925 | $36.94 |
| 10 | 2022 - Q4 (2022-12-31) | $184,603,256 | 2.75% | 4,681,797 | $36.42 |
| 11 | 2022 - Q3 (2022-09-30) | $162,595,000 | 2.46% | 4,504,020 | $35.95 |
| 12 | 2022 - Q2 (2022-06-30) | $133,575,000 | 2.16% | 4,391,038 | $30.24 |
| 13 | 2022 - Q1 (2022-03-31) | $100,894,000 | 1.23% | 3,300,427 | $29.94 |
| 14 | 2021 - Q4 (2021-12-31) | $97,570,000 | 0.99% | 3,123,229 | $29.88 |
| 15 | 2021 - Q3 (2021-09-30) | $23,096,000 | 0.27% | 1,511,543 | $17.38 |
| 16 | 2021 - Q2 (2021-06-30) | $17,598,000 | 0.23% | 945,135 | $18.43 |
| 17 | 2021 - Q1 (2021-03-31) | $13,808,000 | 0.2% | 771,410 | $16.95 |
| 18 | 2020 - Q4 (2020-12-31) | $6,851,000 | 0.11% | 445,444 | $11.70 |
| 19 | 2020 - Q3 (2020-09-30) | $4,996,000 | 0.1% | 451,307 | $11.77 |
| 20 | 2020 - Q2 (2020-06-30) | $5,821,000 | 0.14% | 464,233 | $12.73 |
| 21 | 2020 - Q1 (2020-03-31) | $5,243,000 | 0.17% | 462,332 | $14.24 |
The displayed share prices are average quarterly stock market prices.